Unmasking Biases and Reliability Concerns in Convolutional Neural Networks Analysis of Cancer Pathology Images
arXiv cs.AI / 3/16/2026
💬 OpinionIdeas & Deep AnalysisModels & Research
Key Points
- The study analyzes 13 widely used cancer benchmark datasets using four CNN architectures across cancer types such as melanoma, carcinoma, colorectal cancer, and lung cancer to evaluate current practices.
- It finds that CNNs can achieve high accuracy (up to about 93%) on datasets composed of cropped background segments without clinical content, challenging the validity of such benchmarks.
- The results indicate that some architectures are more biased than others, suggesting that common ML evaluation methods may yield unreliable conclusions in cancer pathology.
- The authors warn that these biases are hard to detect and may mislead researchers who rely on benchmark datasets, underscoring the need for more robust evaluation approaches.
Related Articles
How AI is Transforming Dynamics 365 Business Central
Dev.to
Algorithmic Gaslighting: A Formal Legal Template to Fight AI Safety Pivots That Cause Psychological Harm
Reddit r/artificial
Do I need different approaches for different types of business information errors?
Dev.to
ShieldCortex: What We Learned Protecting AI Agent Memory
Dev.to
How AI-Powered Revenue Intelligence Transforms B2B Sales Teams
Dev.to